Several TSC2-deficient or null cells have been isolated from AML patients previously, but isolating and establishing sustained cultures of AML and LAM cells has been challenging [22], [23], [24], in part because of the heterogeneity of LAM nodules [25]. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.